Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development
Commentary|Videos|August 5, 2024

Being Responsible with Artificial Intelligence Solutions

In part 4 of this video interview, Rama Kondru, PhD, CEO of Veridix AI discusses best practices for choosing the right artificial intelligence solutions.

When vendors are evaluating which artificial intelligence (AI) solutions are best for them, what should they be keeping top of mind?

Kondru: It's a great question. There's a lot of companies that are popping up in the AI space with LLMs (large language models). The factors that one needs to think about is performance and reliability. The second one is, do they have built-in guardrails to ensure data integrity and patient safety within the life sciences sector? AI has a different meaning for our participants and folks across the globe, and having this keen eye on the guardrails for data integrity and patient safety is a must. Some of the considerations that I would include when I'm looking at a vendor race, are there business goals aligned? For us, I think in the end, we serve the participants and the patients, and our hope is to impact human health, so is there a business alignment there? How is the data infrastructure? Are there any safeguards or guardrails around patient data privacy? We also want to make sure that there are ethical considerations. We talked about patient recruitment and site selection—are there inherent biases? Is there fairness, transparency, and accountability? These are some of the things that I would look at when I'm picking out a vendor in the AI space or LLM space.


Related to this article

Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Where AI Governance in Clinical Development Falls Short
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, identifies three recurring failure modes in AI governance frameworks—and explains why responsible AI must be an ongoing operating discipline, not a one-time approval gate.